Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate or Methylprednisolone in CRwNP
NCT04532736Phase 2Completed
- Sponsor
- Dokuz Eylul University
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, methylprednisolone in chronic rhinosinusitis with nasal polyposis (CRSwNP), sponsored by Dokuz Eylul University. Started Sep 2017; status: completed.
02
Drugs
methotrexatemethylprednisolone
03
Conditions
chronic rhinosinusitis with nasal polyposis (CRSwNP)
Beyond the preview
Go deeper on NCT04532736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04532736.